GDN Ventures Buys Gaudium IVF Stake, Shares Surge 12.56%

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
GDN Ventures Buys Gaudium IVF Stake, Shares Surge 12.56%
Overview

GDN Ventures acquired a 1.37% stake in Gaudium IVF and Women Health for Rs 8.58 crore on April 9. The deal sent Gaudium IVF shares up 12.56% to Rs 89.17. The day also saw other bulk deals, like Arihant Capital Markets buying into Sai Parenterals and Trendview Capital Fund selling stakes.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

GDN Buys Gaudium IVF Stake

GDN Ventures, a Rajasthan-based limited liability partnership, bought 10 lakh shares, or 1.37% of Gaudium IVF and Women Health, for Rs 8.58 crore. The shares were acquired at Rs 85.84 each, driving up the fertility care company's stock.

Gaudium IVF Shares Jump 12.56%

Gaudium IVF shares jumped 12.56% to Rs 89.17 on high trading volumes following the bulk deal. The company, which listed on February 27, has performed well, already gaining almost 13% from its initial offering price of Rs 79.

Other Bulk Deals on April 9

Other bulk deals on April 9 included Arihant Capital Markets acquiring 3.98 lakh shares (0.9% stake) in pharmaceutical firm Sai Parenterals for Rs 16.84 crore. Trendview Capital Fund sold shares in Striders Impex and Marushika Technology. Minerva Ventures Fund also bought a stake in Expo Engineering and Projects, while Niraalie Meynon sold her holdings.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.